GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of GTx-758 on Serum Prostate-specific
antigen (PSA) levels in men with castrate resistant prostate cancer who are maintained on
androgen deprivation therapy (Serum PSA response and Serum PSA progression)